FDA Approved: EKTERLY — Original Application (KalVista Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved EKTERLY (SEBETRALSTAT) from KalVista Pharmaceuticals Ltd through an original NDA for the treatment of hereditary angioedema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• EKTERLY (SEBETRALSTAT)

Snippet

ORIG AP for EKTERLY (SEBETRALSTAT)